Product Added Successfully.Please click cart button to proceed
Uploaded Successfully
Thank you for choosing TimesMed Pharmacy
Our representatives will contact you as soon as possible. If you want to reach us immediately, please call 98 8455 5001
Abiratas 250mg Tablet
PRODUCT DETAILS
About Abiratas 250mg Tablet
It is used to treat metastatic prostate cancer in adult men. It is generally used in combination with prednisone or prednisolone to lower the risk of high blood pressure, edema (fluid retention in your body) or decrease in blood potassium levels. It can also be used in combination with androgen deprivation therapy to lower testosterone levels in case of early-stage hormone sensitive prostate cancer.
Uses of Abiratas 250mg Tablet
Abiraterone Acetate is used in the treatment of prostate cancer
Medicinal Benefits of Abiratas 250mg Tablet
Abiraterone Acetate is an anticancer medication. It works by preventing androgen (male hormone) production in man. This is done by inhibiting an enzyme (CYP17) that is responsible for the production of androgen. This is how it slows down the growth of prostate cancer.
Directions for Use
Take this medicine either 1 hour before or 2 hours after eating meals. Swallow the medicine completely with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose for you depending upon your condition. Continue to take this medicine, as long as your doctor tells you to do so, to obtain better results.
Side Effects of Abiratas 250mg Tablet
Vomiting, Decreased potassium level in blood, Edema (swelling), Decreased white blood cell count, Fatigue, Increased liver enzymes, High blood pressure, Urinary tract infection, Diarrhea, Anemia (low number of red blood cells), Cough, Hypercholesterolemia (high cholesterol), Hot flashes, Joint swelling, Increased levels of blood fat, Altered blood sugar level
Similar Drugs
For informational purposes only. Consult a doctor before taking any medicines.
Safety Advice
ALCOHOL
Avoid consumption of alcohol while taking this medicine.